HIGHLIGHTS
- who: Chenping Du and colleagues from the Diabetes Complications Group, Mater Research Institute-The University of Queensland, Translational Research Institute, Woolloongabba, Australia have published the paper: Advanced Glycation End Products and Inflammation in Type 1 Diabetes Development, in the Journal: Cells 2022, 11, 3503. of /2022/
- what: Prevention strategies for T1D in the early stages are a major goal of current research.
- future: More research into AGEs and scavenger receptor family is required to understand whether these receptors are involved in the modulation of immune activity in T1D and whether they have similar . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.